East Bay biotech nets Stanford spinout to figure out what turns genes off, on

Softbank and Foresite-backed 10x Genomics of Pleasanton snags an epigenetics technology company as its first acquisition.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.